» Articles » PMID: 36611832

Rescue of Misfolded Organic Cation Transporter 3 Variants

Overview
Journal Cells
Publisher MDPI
Date 2023 Jan 8
PMID 36611832
Authors
Affiliations
Soon will be listed here.
Abstract

Organic cation transporters (OCTs) are membrane proteins that take up monoamines, cationic drugs and xenobiotics. We previously reported novel missense mutations of organic cation transporter 3 (OCT3, SLC22A3), some with drastically impacted transport capabilities compared to wildtype. For some variants, this was due to ER retention and subsequent degradation of the misfolded transporter. For other transporter families, it was previously shown that treatment of misfolded variants with pharmacological and chemical chaperones could restore transport function to a certain degree. To investigate two potentially ER-bound, misfolded variants (D340G and R348W), we employed confocal and biochemical analyses. In addition, radiotracer uptake assays were conducted to assess whether pre-treatment with chaperones could restore transporter function. We show that pre-treatment of cells with the chemical chaperone 4-PBA (4-phenyl butyric acid) leads to increased membrane expression of misfolded variants and is associated with increased transport capacity of D340G (8-fold) and R348W (1.5 times) compared to untreated variants. We herein present proof of principle that folding-deficient SLC22 transporter variants, in particular those of OCT3, are amenable to rescue by chaperones. These findings need to be extended to other SLC22 members with corroborated disease associations.

Citing Articles

The effect of 4-phenylbutyrate and sodium 4-phenylbutyrate on genetic mutation diseases: A meta-analysis.

Tang W, Cai D, Song Y, Liao Z, Lian J Medicine (Baltimore). 2025; 104(2):e40818.

PMID: 39792717 PMC: 11730837. DOI: 10.1097/MD.0000000000040818.


On the linkage of thermodynamics and pathogenicity.

Pandey P, Ghimire S, Wu B, Alexov E Curr Opin Struct Biol. 2023; 80:102572.

PMID: 36965249 PMC: 10239362. DOI: 10.1016/j.sbi.2023.102572.

References
1.
Said G, Grippon S, Kirkpatrick P . Tafamidis. Nat Rev Drug Discov. 2012; 11(3):185-6. DOI: 10.1038/nrd3675. View

2.
Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

3.
Gasser P, Hurley M, Chan J, Pickel V . Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct. 2016; 222(4):1913-1928. PMC: 5362368. DOI: 10.1007/s00429-016-1315-9. View

4.
Ng J, Barral S, De La Fuente Barrigon C, Lignani G, Erdem F, Wallings R . Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Sci Transl Med. 2021; 13(594). PMC: 7612279. DOI: 10.1126/scitranslmed.aaw1564. View

5.
Goswami S, Gong L, Giacomini K, Altman R, Klein T . PharmGKB summary: very important pharmacogene information for SLC22A1. Pharmacogenet Genomics. 2014; 24(6):324-8. PMC: 4035531. DOI: 10.1097/FPC.0000000000000048. View